Skip to main content

Advertisement

Table 1 Patient groups

From: Expression, regulation and clinical significance of soluble and membrane CD14 receptors in pediatric inflammatory lung diseases

  Pneumonia Cystic fibrosis Asthma Controls
  bacterial non-bacterial    
N 31 17 39 15 8
Age [yrs] 10 ± 5 12 ± 7 11 ± 6 10 ± 4 9 ± 4
Sex (m:f) 19/12 9/8 23/16 7/8 5/3
CRP (mg/l) 114 ± 64 53 ± 25 8 ± 3 12 ± 4 2 ± 1
WBC (109/l) 20 ± 8 11 ± 5 9 ± 4 10 ± 5 8 ± 2
Atopy 4/31 5/17 11/39 15/15 0/8
FEV1 (% pred) - - 95 ± 20 68 ± 12 -
FVC (% pred) - - 93 ± 19 73 ± 26 -
Bacteria detected 31 0 30/39 3/15 0/8
BALF cells      
Viability (%) 76 ± 20 70 ± 14 76 ± 34 81 ± 26 85 ± 13
Recovery (%) 62 ± 24 52 ± 18 42 ± 17 56 ± 11 58 ± 18
Total cells (103/ml) 962 ± 303 712 ± 144 3240 ± 9380 240 ± 113 145 ± 23
Neutrophils (%) 38 ± 24 10 ± 13 63 ± 31 16 ± 23 2 ± 1
Macrophages (%) 55 ± 28 62 ± 34 33 ± 16 74 ± 21 87 ± 9
Lymphocytes (%) 12 ± 16 20 ± 11 5 ± 3 13 ± 14 5 ± 3
Eosinophils (%) 4 ± 2 2 ± 3 2 ± 1 5 ± 2 0 ± 0
Mast cells (%) 1 ± 1 1 ± 2 1 ± 1 2 ± 1 0 ± 1
Plasma cells (%) 4 ± 7 8 ± 5 3 ± 4 6 ± 4 2 ± 1
BALF cells analyzed by flow cytometry 15/31 8/17 9/39 13/15 8/8
  1. results are expressed as means ± SD; m: male, f: female; WBC: white blood count; FEV1: Forced expiratory volume in 1 second (% of predicted); FVC: Forced vital capacity (% of predicted); BALF: bronchoalveolar lavage fluid; CRP: C-reactive protein; WBC: white blood cell count; *Pathogens detected in any patients sample at time of study (blood, BALF or sputum).